ID
|
Author
|
Year
|
Title
|
Publisher
|
1194633 |
Aschmann, Yvonne Zysset; Kummer, Oliver; Linka, André; Wenk, Markus; Azzola, Andrea; Bodmer, Michael; Krähenbühl, Stephan; Haschke, Manuel |
2008 |
Pharmacokinetics and pharmacodynamics of sildenafil in a patient treated with human immunodeficiency virus protease inhibitors |
Therapeutic drug monitoring |
4615202 |
Bachmann, Fabio; Duthaler, Urs; Meyer Zu Schwabedissen, Henriette E.; Puchkov, Maxim; Huwyler, Jörg; Haschke, Manuel; Krähenbühl, Stephan |
2021 |
Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2 |
Clinical Pharmacology and Therapeutics |
4493363 |
Bachmann, Fabio; Duthaler, Urs; Rudin, Deborah; Krähenbühl, Stephan; Haschke, Manuel |
2018 |
N-demethylation of N-methyl-4-aminoantipyrine, the main metabolite of metamizole |
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences |
4627070 |
Bachmann, Fabio; Meyer Zu Schwabedissen, Henriette E; Duthaler, Urs; Krähenbühl, Stephan |
2022 |
Cytochrome P450 1A2 is the most important enzyme for hepatic metabolism of the metamizole metabolite 4-methylaminoantipyrine. |
British journal of clinical pharmacology |
4405427 |
Berger, B.; Donzelli, M.; Maseneni, S.; Boess, F.; Roth, A.; Krahenbuhl, S.; Haschke, M. |
2016 |
Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail |
Front Pharmacol |
4493342 |
Berger, Benjamin; Bachmann, Fabio; Duthaler, Urs; Krähenbühl, Stephan; Haschke, Manuel |
2018 |
Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe Drug |
Frontiers in pharmacology |
4641929 |
Blaser, Lea S.; Duthaler, Urs; Bouitbir, Jamal; Leuppi-Taegtmeyer, Anne B.; Liakoni, Evangelia; Dolf, Reto; Mayr, Michael; Drewe, Jürgen; Krähenbühl, Stephan; Haschke, Manuel |
2021 |
Comparative Effects of Metamizole (Dipyrone) and Naproxen on Renal Function and Prostacyclin Synthesis in Salt-Depleted Healthy Subjects - A Randomized Controlled Parallel Group Study |
Frontiers in Pharmacology |
2829453 |
Blaser, Lea S; Tramonti, Alexandra; Egger, Pascal; Haschke, Manuel; Krähenbühl, Stephan; Rätz Bravo, Alexandra E |
2015 |
Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports |
European journal of clinical pharmacology |
4211103 |
Blaser, Lea; Hassna, Hala; Hofmann, Sarah; Holbro, Andreas; Haschke, Manuel; Rätz Bravo, Alexandra; Zeller, Andreas; Krähenbühl, Stephan; Taegtmeyer, Anne |
2017 |
Leucopenia associated with metamizole: a case-control study |
Swiss medical weekly |
3418773 |
Bloechliger, Marlene; Ceschi, Alessandro; Rüegg, Stephan; Kupferschmidt, Hugo; Krähenbühl, Stephan; Jick, Susan S.; Meier, Christoph R.; Bodmer, Michael |
2016 |
Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case-Control Analysis Using the Clinical Practice Research Datalink |
Drug Safety |
1192857 |
Bodmer, Michael; Brauchli, Yolanda B; Krähenbühl, Stephan; Jick, Susan S; Meier, Christoph R |
2009 |
Statin use and risk of gallstone disease followed by cholecystectomy |
JAMA : the journal of the American Medical Association |
1195839 |
Bodmer, Michael; Burkard, Thilo; Kummer, Oliver; Beyrau, Ralf; Krähenbühl, Stephan; Haschke, Manuel |
2008 |
Pharmacokinetics and pharmacodynamics of quetiapine in a patient with a massive overdose |
Therapeutic drug monitoring |
1192570 |
Bodmer, Michael; Link, Bettina; Grignaschi, Nathalie; Kummer, Oliver; Ruegg, Stephan; Haschke, Manuel; Krähenbühl, Stephan |
2008 |
Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam |
Therapeutic drug monitoringNew York : Raven Press |
1196986 |
Bodmer, Michael; Meier, Christian; Krähenbühl, Stephan; Jick, Susan S; Meier, Christoph R |
2008 |
Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia : a nested case-control analysis |
Diabetes Care |
1193351 |
Bodmer, Michael; Meier, Christian; Krähenbühl, Stephan; Jick, Susan S; Meier, Christoph R |
2010 |
Long-term metformin use is associated with decreased risk of breast cancer |
Diabetes care |
2829454 |
Bonifacio, Annalisa; Mullen, Peter J.; Mityko, Ileana Scurtu; Navegantes, Luiz C.; Bouitbir, Jamal; Krähenbühl, Stephan |
2016 |
Simvastatin induces mitochondrial dysfunction and increased atrogin-1 expression in H9c2 cardiomyocytes and mice in vivo |
Archives of Toxicology |
3394656 |
Bonifacio, Annalisa; Sanvee, Gerda M.; Bouitbir, Jamal; Krähenbühl, Stephan |
2015 |
The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity |
Biochimica et biophysica acta. Molecular cell research |
3826625 |
Bonifacio, Annalisa; Sanvee, Gerda M.; Brecht, Karin; Kratschmar, Denise V.; Odermatt, Alex; Bouitbir, Jamal; Krähenbühl, Stephan |
2017 |
IGF-1 prevents simvastatin-induced myotoxicity in C2C12 myotubes |
Archives of Toxicology |
1194634 |
Botomino, Andrea; Bruppacher, Rudolf; Krähenbühl, Stephan; Hersberger, Kurt E |
2008 |
Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling in pharmacies |
Pharmacy world & science |
4602364 |
Bouitbir, Jamal; Alshaikhali, Abdallah; Panajatovic, Miljenko V.; Abegg, Vanessa F.; Paech, Franziska; Krähenbühl, Stephan |
2020 |
Mechanisms of Cardiotoxicity Associated with Tyrosine Kinase Inhibitors in H9c2 Cells and Mice |
European cardiology |